| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.009 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |